Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)

NCT04742010 is registered in ClinicalTrials.gov with Stinus Gadegaard Hansen as lead sponsor.

NCT NCT04742010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04742010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)
Lead sponsor
Stinus Gadegaard Hansen
Phase
Phase 2
Overall status
Completed
Start date
February 20, 2021
Completion date
August 12, 2024
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery, bone loss, muscle atrophy